Skip to main content
Log in

Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside

  • Articles
  • Published:
Medical Oncology and Tumor Pharmacotherapy Aims and scope Submit manuscript

Abstract

Eight patients with inaspiratable bone marrows due to significant degrees of fibrosis were treated with high dose cytosine arabinoside because of either documented or suspected coexistent acute leukemia. The peripheral blood counts returned to normal in 7 patients. Remissions were short lived and bone marrow abnormalities persisted suggesting that consolidation therapy should be administered to these patients as soon as their peripheral blood counts are normalized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Clough V: Myelofibrosis in chronic granulocytic leukemia.Br J Haemat 42, 515 (1979).

    Article  CAS  Google Scholar 

  2. Preisler, H D, Early, A P, Raza, A.et al: Therapy for secondary acute nonlymphocytic leukemia with cytosine arabinoside.New Engl J Med 308, 21 (1983).

    PubMed  CAS  Google Scholar 

  3. Bird T and Proctor S J: Malignant myelosclerosis. Myeloproliferative disorder of leukemia?Am J Clin Pathol 67, 512 (1977).

    PubMed  CAS  Google Scholar 

  4. Patel A R, Shoh P C and Rhee H I: Acute myelofibrosis and acute myeloblastic leukemia.Br Med J 2, 1232 (1976).

    Article  PubMed  CAS  Google Scholar 

  5. Manoharan A and Pitney W R: Acute myeloblastic leukemia with marrow fibrosis (malignant myelosclerosis): acute leukemia or malignant myelosclerosis?Aust NZ J Med 7, 638 (1977).

    CAS  Google Scholar 

  6. Breton-Gorius J, Reyes F, Duhamel G.et al: Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase.Blood 51, 45 (1978).

    PubMed  CAS  Google Scholar 

  7. den Ottolander G J, te Velde J, Brederoo P.et al: Megakaryoblastic leukemia (acute myelofibrosis): a report of three cases.Br J Haemat 42, 9 (1979).

    Article  Google Scholar 

  8. Sultan C, Sigaux F, Imbert M and Reyes F: Acute myelodysplasia with myelofibrosis: a report of eight cases.Br J Haemat 49, 11 (1981).

    Article  CAS  Google Scholar 

  9. Bevan D, Rose M and Greaves M: Leukemia of platelet precursors: diverse features in four cases.Br J Haemat 51, 147 (1982).

    Article  CAS  Google Scholar 

  10. Quesenberry P J, Rappeport J M, Fountebuoni A,et al: Inhibition of normal hematopoiesis by leukemic cells.New Engl J Med 299, 71 (1978).

    PubMed  CAS  Google Scholar 

  11. Broxmeyer H E, Grossbard E, Jacoben N and Moore M A S: Persistence of inhibitory activity against normal bone marrow cells during remission of acute leukemia.New Engl J Med 301, 346 (1979).

    PubMed  CAS  Google Scholar 

  12. Chan W C, Brynes R K, Kim T H,et al: Acute megakaryoblastic leukemia in early childhood.Blood 62, 92 (1983).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Preisler, H.D., Raza, A. & Barcos, M. Treatment of dysmyelopoietic/leukemic syndromes with myelofibrosis and megakaryocytic hyperplasia with large doses of cytosine arabinoside. Med. Oncol. & Tumor Pharmacother. 2, 87–91 (1985). https://doi.org/10.1007/BF02934853

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02934853

Keywords

Navigation